Dr Paige Mumford is a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She completed a PhD, and is now working as a postdoctural researcher, in Neuroscience at the UK Dementia Research Institute, where she works in Dr Frances Wiseman's team at University College London (UCL). Her research explores how neuroinflammation in Alzheimer's disease is different in people with Down's syndrome than it is in people without Down's syndrome, due to specific chromosome 21 genes, and her work focuses on genes involved in interferon response. Previously, she studied Cognitive Neuroscience at the University of California, Berkeley, and went on to obtain an MSc in Neuroscience at UCL.D
Fifteen studies comprehensively mapping the genes responsible for regulation of activity and development of the brain have been published...
Having two copies of a gene variant known to increase the risk of developing Alzheimer's disease, may actually cause the disease...
UK fertility clinics have maintained their run of reporting none of the most serious types of adverse incidents for the second year running, a Human Fertilisation and Embryology Authority report has shown...
A new method for the creation of tumour organoids has been developed, which allows them to be used with advanced imaging to study cancer in greater detail...
The specific pathway that blood stem cells use to degrade proteins to keep themselves clean and healthy has been discovered, and that this process becomes disrupted with age...
A gene variant which increases risk of developing Alzheimer's disease may do so by decreasing production of the substance which insulates nerve cells...
A new pathway involved in the breaking and repairing of noncoding DNA has been discovered, which may lead to new treatments for neurological diseases...
A form of CRISPR which allows genes to be turned on and off has been used to investigate the role of genetic variants that affect the microglia cells, in the development of Alzheimer's disease...
A novel gene therapy which uses base editing to lower cholesterol has been given to the first patient in a clinical trial...
A new international study has found 42 genes associated with an increased risk of developing Alzheimer's disease that had not been previously known...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
